Oyster Point Pharma, Inc. Proceeds from Issuance Initial Public Offering
Oyster Point Pharma, Inc. reported Proceeds from Issuance Initial Public Offering of $95.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2022-02-24
- Oyster Point Pharma, Inc. proceeds from issuance initial public offering for fiscal 2021 was $95.00M.
- Oyster Point Pharma, Inc. proceeds from issuance initial public offering for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Oyster Point Pharma, Inc. proceeds from issuance initial public offering for fiscal 2019 was $82.10M.
- Oyster Point Pharma, Inc. proceeds from issuance initial public offering for fiscal 2018 was $0.00.
| Period end | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|
| 2021-12-31 | $95.00M 10-K · filed 2022-02-24 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 |
| 2019-12-31 | $82.10M 10-K · filed 2021-02-18 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |